Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan

Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong – A decision analysis

(2015) Joyce H S You et al.   Human Vaccines & Immunotherapeutics

Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK

(2015) G. Meier et al.   JOURNAL OF MEDICAL ECONOMICS

The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model

(2014) Laure-Anne Van Bellinghen et al.   PLoS One

The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required

(2014) Anthony T. Newall et al.   VACCINE

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

(2014) Juan Carlos Tinoco et al.   VACCINE

Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States

(2014) Karen M Clements et al.   Human Vaccines & Immunotherapeutics

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

(2013) Dorothee Kieninger et al.   BMC INFECTIOUS DISEASES

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

(2013) Joanne M. Langley et al.   JOURNAL OF INFECTIOUS DISEASES

Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011−12 Season

(2013) Yi-Chun Lo et al.   PLoS One

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults

(2013) Stéphanie Pépin et al.   VACCINE

Quadrivalent influenza vaccine in the United States

(2013) Manika Suryadevara et al.   Human Vaccines & Immunotherapeutics

Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children

(2012) Stan L. Block et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults

(2012) David P. Greenberg et al.   VACCINE

The rationale for quadrivalent influenza vaccines

(2012) Christopher S. Ambrose et al.   Human Vaccines & Immunotherapeutics

Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/Yamagata

(2011) Danuta M. Skowronski et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults

(2011) Stan L. Block et al.   VACCINE

Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection

(2009) Daisuke Ikeno et al.   MICROBIOLOGY AND IMMUNOLOGY

Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007

(2008) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season

(2008) Edward A. Belongia et al.   JOURNAL OF INFECTIOUS DISEASES